Skip to main content
Equibles
INGR logo

INGR · Ingredion Inc

Track INGR — free

Use INGR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INGR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$94.14 +1.42 (+1.53%) At close · Nov 13
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$5.86B
Shares
62.29M
Volume · Nov 13 564.71K Avg daily vol (3M) 695.26K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$94.14 Open$93.33 Day$93.06–94.22 52W close$91.72–120.41 Avg vol 30d801K Short int4.6M · 7.3% of shares · 6.4d Short vol72% Last earningsNov 5, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 6

Up next

Next earnings call
Feb 2, 2027 Est · unconfirmed · in 11 wks
Q3 2026 earnings call transcript
call held Nov 5, 2026
Play latest call

Latest documents

2026
Nov 6
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Net income falls as Tate & Lyle acquisition advances

Ingredion's year-to-date 2026 net income fell to $398 million from $564 million as higher costs and a Bedford Park thermal event pressured results. The pending all-cash Tate & Lyle acquisition values its equity at approximately £2.7 billion, or approximately $3.5 billion.

Revenue $1.79B ▼ 1.3% Net income $142M ▼ 17.0% Diluted EPS $2.23 ▼ 14.6%
Read from the MD&A section
2 source passages
Net income attributable to Ingredion for year-to-date 2026 decreased to $398 million from $564 million for year-to-date 2025, primarily driven by impacts associated with a second-quarter thermal event at our Bedford Park, Illinois manufacturing facility (the “Argo facility”) and higher manufacturing costs and raw materials inputs. The pending acquisition values the equity of Tate & Lyle at approximately £2.7 billion, or approximately $3.5 billion based on the British pound sterling to U.S. dollar exchange rate on September 30, 2026. Open the document at this passage
Nov 5
Earnings call
2026 outlook lowered as Argo costs and demand pressure earnings

Ingredion lowered its 2026 outlook as higher Argo manufacturing costs, tapioca inflation, soft demand and a stronger Mexican peso reduced profitability; adjusted EPS is now expected to be $9.25 to $9.70.

3 source passages
Welcome to the third quarter 2026 Ingredion Incorporated Earnings Conference Hall. Our third quarter results fell short of our expectations. Excluding the sale of our Pakistan business, net sales grew 2%, but profitability came under pressure, driven mainly by higher manufacturing costs at Argo, along with higher net input costs and the impact of a stronger Mexican peso. For the full year 2026, we anticipate net sales to be flat. Adjusted operating income to be down mid-teens, reflecting the operational challenges in food and industrial ingredients US-Canada. We expect full-year adjusted EPS to be in the range of $9.25 to $9.70. Open the document at this passage
Nov 5
Current report 8-K
Operating income falls 19%, full-year outlook lowered

Ingredion reported third-quarter operating income down 19% and lowered full-year reported diluted EPS guidance to $8.04 to $8.49 and adjusted diluted EPS guidance to $9.25 to $9.70.

Financial results
2 source passages
•Third quarter 2026 reported and adjusted operating income both decreased 19% compared to the third quarter 2025 The Company now expects its full-year 2026 reported diluted EPS to be in the range of $8.04 to $8.49, and its adjusted diluted EPS to be in the range of $9.25 to $9.70. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$7.19B
Trailing 12 months
Net income (TTM)
$563.00M
Trailing 12 months
Revenue growth YoY
-1.3%
Year over year
Operating margin
11.3%
Trailing 12 months
P / E (TTM)
10.7
Trailing earnings · reciprocal yield 9.3%
FCF yield
5.9%
TTM · current market cap
Return on invested capital
11.2%
Trailing 12 months
Net cash
−$786.00M
Latest balance sheet
Dividend yield
3.5%
Trailing 12 months
Shares change YoY
-2.6%
Year over year · fewer shares
Price change (1Y)
-12.6%
Trailing year
Short interest
7.3%
Latest settlement · 6.4 days to cover
View all 125 metrics

Quarterly results

Revenue Net income Net loss
▼6.3% $1.80B $95.00M '24 Q4 ▼3.7% $1.81B $197.00M '25 Q1 ▼2.4% $1.83B $196.00M '25 Q2 ▼2.9% $1.82B $171.00M '25 Q3 ▼2.4% $1.76B $165.00M '25 Q4 ▼1.2% $1.79B $142.00M '26 Q1 ▲0.9% $1.85B $114.00M '26 Q2 LATEST ▼1.3% $1.79B $142.00M '26 Q3

AI Brief

Q3 FY26 earnings call · Nov 5, 2026
Q3 FY26

TL;DR. T&HS delivered a 10th consecutive quarter of volume growth, LATAM sales rose 7%, Argo production stabilized, the Tate & Lyle acquisition progressed, and shareholder returns continued. Operating income, adjusted diluted EPS and year-to-date cash from operations declined, full-year guidance was lowered, and Argo costs, weak demand, higher tapioca costs, currency effects and earthquake disruption remained material headwinds.

Bullish
  • + Texture & Healthful Solutions delivered its 10th consecutive quarter of net sales volume growth, supported by global clean-label demand. new
  • + Excluding Pakistan, third-quarter net sales increased 2%, driven by favorable foreign exchange and higher volumes in F&II–LATAM and T&HS. new
  • + Argo production remained stable for a second consecutive quarter and inventories of key products were largely rebuilt. new
  • + The Tate & Lyle acquisition continued through regulatory and antitrust reviews, with a target to close in the second half of 2027 and integration planning underway. new
  • + Ingredion raised its quarterly dividend to $0.83 per share, extended its annual increase streak to 12 years, and remained on track to complete $100 million of share repurchases. new
  • + F&II–LATAM third-quarter net sales increased 7%, driven by favorable foreign exchange and higher volumes. new
Bearish
  • − Management lowered full-year guidance to adjusted diluted EPS of $9.25–$9.70 and adjusted operating income down mid-teens, while F&II–U.S./CAN operating income is now expected to decline 35-40%. new
  • − Third-quarter reported and adjusted diluted EPS declined to $2.23 and $2.28 from $2.61 and $2.75, respectively, in the prior-year quarter. new
  • − Higher tapioca costs and manufacturing expense reduced Texture & Healthful Solutions operating income despite positive volume growth. new
  • − F&II–LATAM third-quarter operating income decreased $7 million to $109 million, primarily because of Mexican peso transaction effects and earthquake-related disruption in Colombia. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Strong Quant / Vol Low
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −10%
below
Price vs 50-day avg −3%
below
RSI (14) 46
neutral
MACD trend Negative
52-week position 8%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −4%
trailing
6-month return −9%
trailing
YTD return −15%
this year
Relative strength −9%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $97 › 200d $105 — 200d above 50d
Institutional flow Accumulating
552 of 618 funds reported for Sep 30 · net +1.6M sh shares · +48 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
7.33% of shares out · ▼ -2.4% MoM · 6.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
618 holders — mid 3-yr range
Squeeze score 62
elevated · 0–100
Fundamentals
Strong
Revenue growth −3%
Y/Y
Gross margin 25%
expanding
EPS growth +15%
Y/Y
Free cash flow $511.0M
Valuation P/E 10.7
below peers
Balance sheet $760.0M
net debt
Quant / Vol
risk profile
Low
Volatility 18%
annualized · 1-yr
Max drawdown −24%
past year
ATR 2.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 5
Latest guidance · from the Earnings Call filed Aug 4, 2026
full year 2026
Adjusted earnings per share Non-GAAP Lowered $10.30 – $10.90
May 5, 2026 $10.45 – $11.15 changed to Aug 4, 2026 $10.30 – $10.90
Capital expenditures Raised $450M – $490M
May 5, 2026 $400M – $440M changed to Aug 4, 2026 $450M – $490M
full year
Operating loss $15M
Previous outlook earlier release · from the Earnings Call filed May 5, 2026

Still-open targets the latest release did not restate under the same label.

Financing cost · 2026 $35M – $45M
Guided vs delivered · last 5 settled
GAAP EPS Full-Year 2025
guided $11.11 – $11.31
$11.18 In line
Reported EPS full-year 2024
guided $10.20 – $10.70
$9.71 Miss −7.1%
GAAP EPS Full-Year 2023
guided $9.25 – $9.65
$9.60 In line
Reported EPS full-year 2022
guided $6.90 – $7.20
$7.34 Beat +4.1%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−10% Bearish
Price vs 50-day avg
−3% Neutral
RSI (14)
46 Neutral
MACD trend
Negative Bearish
52-week position
8% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $97 › 200d $105 — 200d above 50d
Institutional flow Accumulating
552 of 618 funds reported for Sep 30 · net +1.6M sh shares · +48 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
7.33% of shares out · ▼ -2.4% MoM · 6.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
618 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $92 Now $94 · 8% Range high $120
vs 200-day avg -10% vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted diluted EPS non-GAAP $5.16 Six Months Ended June 30, 2026 —
Adjusted effective income tax rate non-GAAP 26.3% Six Months Ended June 30, 2026 —
All Other net sales 124M second quarter 2026 —
All Other operating income 6M second quarter 2026 —
Cash, including short-term investments 952M June 30, 2026 —
Dividends paid 52M second quarter 2026 —
Food & Industrial Ingredients–LATAM net sales 611M second quarter 2026 —
Food & Industrial Ingredients–LATAM segment operating income 118M second quarter 2026 —
Food & Industrial Ingredients–U.S./CAN net sales 488M second quarter 2026 —
Food & Industrial Ingredients–U.S./CAN segment operating income 58M second quarter 2026 —
Net capital expenditures 210M year-to-date through June 30, 2026 —
Non-GAAP adjusted net income attributable to Ingredion non-GAAP $330M Six Months Ended June 30, 2026 —
Texture & Healthful Solutions net sales 627M second quarter 2026 —
Texture & Healthful Solutions segment operating income 117M second quarter 2026 —
Total debt 1.8B June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
INGR
Ingredion Inc
this stock
$5.86B -14.6% -2.8% 10.7 7.3%
JBS
Jbs N.V.
 $40.00B -15.7% — — 1.3%
KHC
Kraft Heinz Co
 $29.73B +3.5% -0.1% — 8.7%
GIS
General Mills Inc
 $18.35B -26.2% +4.1% — 7.0%
SJM
J M SMUCKER Co
 $14.17B +35.7% +3.7% — 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
610
% held
102.7%
Reported
552 of 618
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
477
View
Short & Settlement
Short Interest Falling
Shares short
4.6M
Days to cover
6.4d
Change
-113.1K sh
View
Short Volume
Short vol %
72%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
470
Value
$45.7K
As of
Oct 14, 2026
View
Off-Exchange
Off-exchange %
38.8%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Oct 14, 2025
View
Financials
Financials
Revenue (FY)
$7.2B
Net income (FY)
$729.0M
EPS diluted
$11.18
View
Buybacks
Authorized
shares 8.0M
Remaining
shares 6.6M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 6, 2026
This year
27

Ingredion's year-to-date 2026 net income fell to $398 million from $564 million as higher costs and a Bedford Park thermal event pressured results. The pending all-cash Tate & Lyle acquisition values its equity at approximately £2.7 billion, or approximately $3.5 billion.

View
Proposed Sales
Value
$170.0K
Shares
1.7K
Filed
Aug 5, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 17, 2026
Last webcast
Nov 5, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
INGR +2.6% -3.9% -8.9% -2.9% -14.6%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY +0.1% -2.7% -9.4% -2.7% -25.2%

Capital returns

Latest dividend
$0.83 / share · ex Oct 1, 2026
Raised 1.2%
Paid (TTM)
$3.29 / share · 4 payouts
Dividend yield (TTM, derived)
3.49%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
shares 8.00M
Spent (derived)
shares 1.40M
Remaining
shares 6.60M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1046257 CUSIP 457187102 13F (30d) 499 filings 444 filers Visit website Investor relations